TOMBESI PAOLO 4
4 · Turning Point Therapeutics, Inc. · Filed Jul 27, 2021
Insider Transaction Report
Form 4
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2021-07-26+13,600→ 13,600 total - Award
Stock Option (right to buy)
2021-07-26+61,200→ 61,200 totalExercise: $62.63Exp: 2031-07-25→ Common Stock (61,200 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]25% of the shares vest on July 26, 2022 and 1/48th of the shares vest monthly thereafter over the next three years.